Treatment Information

Back

Liver Cancer treatment details. Chemotherapy.

University of Bologna , Bologna, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:4City/State/Province:Bologna
Treatments:ChemotherapyHospital:University of Bologna
Drugs:Journal:Link
Date:Jun 2015

Description:

Patients:
This study involved 26 hepatocellular carcinoma patients who had been previously treated with sorafenib. The median patient age was 66 years and 88.4% were male.

Treatment:
Patients received chemotherapy with capecitabine.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 hand-foot syndrome and cardiac failure.

Results:
The median overall survival was 8 months.

Support:
Some of the authors have received support from various pharmaceutical companies.

Correspondence: Dr. Alessandro Granito; email: [email protected]



Back